AU669947B2 - Process for preparing recombinant and synthetic peptides, and their use - Google Patents

Process for preparing recombinant and synthetic peptides, and their use

Info

Publication number
AU669947B2
AU669947B2 AU52557/93A AU5255793A AU669947B2 AU 669947 B2 AU669947 B2 AU 669947B2 AU 52557/93 A AU52557/93 A AU 52557/93A AU 5255793 A AU5255793 A AU 5255793A AU 669947 B2 AU669947 B2 AU 669947B2
Authority
AU
Australia
Prior art keywords
synthetic peptides
peptides
preparing recombinant
microorganisms
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU52557/93A
Other versions
AU5255793A (en
Inventor
Ulrich Grundmann
Thomas Wissel
Gerd Zettlmeissl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU5255793A publication Critical patent/AU5255793A/en
Application granted granted Critical
Publication of AU669947B2 publication Critical patent/AU669947B2/en
Assigned to DADE BEHRING MARBURG GMBH reassignment DADE BEHRING MARBURG GMBH Request to Amend Deed and Register Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to a process for the production of peptides which bind to a predetermined specific binding partner, which includes the setting up of a nucleotide bank, the transformation of microorganisms, the cultivation of the transformed microorganisms and the selection of the microorganisms which express the peptides which are sought, and to the use of such peptides.
AU52557/93A 1992-12-23 1993-12-21 Process for preparing recombinant and synthetic peptides, and their use Ceased AU669947B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4243770 1992-12-23
DE4243770A DE4243770A1 (en) 1992-12-23 1992-12-23 Process for the production of recombinant and synthetic peptides and their use

Publications (2)

Publication Number Publication Date
AU5255793A AU5255793A (en) 1994-07-07
AU669947B2 true AU669947B2 (en) 1996-06-27

Family

ID=6476332

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52557/93A Ceased AU669947B2 (en) 1992-12-23 1993-12-21 Process for preparing recombinant and synthetic peptides, and their use

Country Status (7)

Country Link
EP (1) EP0603672B1 (en)
JP (1) JP3386210B2 (en)
AT (1) ATE190653T1 (en)
AU (1) AU669947B2 (en)
CA (1) CA2112193A1 (en)
DE (2) DE4243770A1 (en)
ES (1) ES2144438T3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932425A (en) * 1997-02-18 1999-08-03 Signal Pharmaceuticals, Inc. Compositions and methods for modulating cellular NF-κB activation
WO2003014360A1 (en) * 2001-08-10 2003-02-20 Bioleaders Corporation SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR
JP4351430B2 (en) 2002-10-04 2009-10-28 財団法人癌研究会 Peptide having binding ability to nanographite structure
KR20200000972A (en) 2018-06-26 2020-01-06 주식회사 바이오리더스 SURFACE EXPRESSION VECTORS INCLUDING pgsA, GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND METHOD OF USING VECTORS TO EXPRESS TARGET PROTEIN ON SURFACE OF MICROORGANISM
CN113330119B (en) 2018-10-10 2024-07-12 生物领先公司 Surface expression vector for constitutive high expression using galactose mutarotase gene promoter derived from lactobacillus casei and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017271A1 (en) * 1990-05-01 1991-11-14 Affymax Technologies N.V. Recombinant library screening methods
WO1992000091A1 (en) * 1990-07-02 1992-01-09 Bioligand, Inc. Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017271A1 (en) * 1990-05-01 1991-11-14 Affymax Technologies N.V. Recombinant library screening methods
WO1992000091A1 (en) * 1990-07-02 1992-01-09 Bioligand, Inc. Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Also Published As

Publication number Publication date
DE59309978D1 (en) 2000-04-20
EP0603672B1 (en) 2000-03-15
ES2144438T3 (en) 2000-06-16
AU5255793A (en) 1994-07-07
EP0603672A2 (en) 1994-06-29
CA2112193A1 (en) 1994-06-24
ATE190653T1 (en) 2000-04-15
DE4243770A1 (en) 1994-06-30
JPH07303493A (en) 1995-11-21
JP3386210B2 (en) 2003-03-17
EP0603672A3 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
AU630950B2 (en) Fibronectin binding protein as well as its preparation
AU4453689A (en) Binding protein for insulin-like growth factors
PL313256A1 (en) Protocadherine proteins and their applications
EP0200909A3 (en) Preparation of protein g and/or fragments thereof
FI101542B1 (en) Chemical synthesis process for preparing a fibronectin binding protein or polypeptide
CA2117581A1 (en) Protocadherin, their antibodies and uses
AU669947B2 (en) Process for preparing recombinant and synthetic peptides, and their use
CA2088068A1 (en) Protein structure of the plant toxin gelonin
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
AU5045493A (en) Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein
ATE170537T1 (en) REACTIVE, WATER EMULSIFIABLE BINDERS AND THEIR USE FOR PRODUCING PAINTS
EP0828004A3 (en) Protein disulfide isomerase gene derived from strain of methylotrophic yeast
EP1308514A3 (en) ICAM-4 Materials and Methods
SE8403929D0 (en) RECOMBINANT DNA MOLECULE, TRANSFORMED MICROORGANISMS AND PROCESS FOR PRODUCING PENICILLIN V AMIDASE
DE58906674D1 (en) Process for the selection of productive, amino acid-excreting strains of microorganisms.
EP0771876A4 (en) PROCESS FOR PRODUCING cis-3-HYDROXY-L-PROLINE
MX9703431A (en) Dna sequence and its use.
AU2076001A (en) Modified full length promoters
GB9226928D0 (en) Novel immunoglobulin binding proteins,process for their production & recombinant dna molecules coding therefor

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired